The project aims to test the HIPRA vaccine against COVID-19 in children (including adolescents) and immunocompromised people.

The meeting, in which Dr. Pere Soler participated, showed the results of the first year with the description of new genetic defects associated with severe forms of COVID-19 and novelties in the detection of autoantibodies against interferons.

The platform offers health workers the latest information on infectious and tropical diseases and also serves as a training tool.

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

This initiative has several collaborative projects with the aim of increasing knowledge about rare blood diseases and improving patient care.

The multicenter phase 1 trial has been conducted in patients aged 2 to 21 years with solid tumors unresponsive to standard treatments or in relapse.

The presentations include the one given by Dr. María Pérez Torres, who received the award for the best oral communication for a project on the use of mesenchymal cells to reduce complications after hematopoietic progenitor transplantation.

The donation will go towards two studies aimed at improving the quality of life of paediatric liver transplant patients.

On International Clinical Trials Day, we highlight the increase in VHIR clinical research over the last year.

Thanks to the donation, the Childhood Cancer and Blood Disorders group at VHIR is doing research to explore the use of liquid biopsy for the prediction of the evolution of patients with this rare disease.

Dr. Lucas Moreno is the first author of the international work that presents a series of considerations for early phase studies with the aim of accelerating the arrival of new therapies to patients with childhood cancer.

A study, in which Vall d'Hebron has participated, has analysed all the interventions of this type carried out between 2006 and 2020.

El 20% dels pacients en els quals s’havia trobat alguna predisposició genètica van ser diagnosticats amb algun tipus de tumor i van poder iniciar el tractament de manera precoç.

The funded project is investigating the biological mechanisms of metastasis and hopes to improve the survival of patients with this type of tumor with the development of new therapies.

Els actes amb motiu del Dia de les Malalties Minoritàries fan possible que pacients amb malalties diferents es trobin i s’ajudin

SIOPEN promotes research and the implementation of clinical trials to improve clinical practice in this type of childhood tumor.

RADeep aims to map at the European level the diagnostic methods, demography, survival rate, main clinical features and treatments of rare anaemia disorders patients.

Within the framework of a clinical trial, the first 3D printed medicine in Europe in the pediatric field will be tested.

The selected studies were those of Dr. Carlos Jiménez, from the Cancer and Childhood Hematological Diseases group, and Dr. Eva Coll, from the Biomedical Research in Gynecology group, both members of eCORE-Cancer.